Clinitech Laboratory IPO Allotment Status

How to Check Clinitech Laboratory IPO Allotment Status

How to check IPO allotment status? Since this is a BSE-SME IPO, you can check the allotment status on the BSE website. You can also check on the registrar's website. Remember, after logging in or on the website of the IPO registrar, Bigshare Services Private Limited. You can also use a broker link; in case your broker is giving such a direct linkage. Here are the steps that you need to follow to check the allotment status. Let us see how to check the allotment status on the Registrar's Website.

Clinitech Laboratory IPO Allotment Date: 30 July 2024

How to Check Clinitech IPO Allotment Status on Bigshare Services Private Limited 

Visit the Bigshare Services registrar website for IPO status by clicking on the link below:

https://ipo.bigshareonline.com/IPO_Status.html

There are three things to remember. Firstly, you can just click on the hyperlink given above and directly go to the allotment checking page. The second option, in case you are not able to click on the link, is to copy the link and paste in your web browser. Thirdly, there also a way to access this page via the home page of Bigshare Services Private Ltd by clicking on the IPO Allotment Status link displayed prominently on the home page. It all works the same and leads you to the same landing page.

Once you enter the IPO allotment check landing page of Bigshare Services Private Ltd, you are given the choice to select from 3 servers viz. Server 1, Server 2, and Server 3. There is nothing to be confused about, as these are just server backups in case one of the servers is experiencing too much traffic. You can select any of these 3 servers and in case you are finding problems accessing one of the servers, then try the other one. There is no difference, in which server you select; the output would still be the same. This is just a method to share the server load during peak access times.

What to do, once you reach the landing page?

When you go to the landing page, you will have to select the name of the company first. This company dropdown list will only show the active IPOs, so once the allotment status is finalized, you can select Clinitech Laboratory ltd from the dropdown box. The basis of allotment, in this case, will be finalized on 30 July 2024, so you will be able to access the details on the registrar's website either late on 30 July 2024 or by the middle of 30 July 2024. Once the company is selected from the dropdown box, you have 3 methods to check the allotment status for the IPO.

· Firstly, you can access the allotment status using the Application Number / CAF Number. The CAF is short for Composite Application Form and it is available on the acknowledgement slip given to you when you submit the IPO application. Enter the Application / CAF number and then click on the Search Button. Enter the application exactly it is given in the acknowledgement slip given to you post the IPO application process. After that, you can click on the Search button to get the details of shares allotted to you in the IPO. Before you see the output, you will be asked to enter a 6-digit Captcha code as given. In case, it is not clear, you can toggle for more options. The numeric captcha is to ensure that the person accessing the allotment status is a human being and not bulk robotic access.

· The second option is that you can search by Beneficiary ID of your demat account. From the dropdown box, you must first select the depository name where your demat account is held i.e., NSDL or CDSL. In the case of NSDL, enter the DP id and Client id in separate boxes as provided. NSDL will be an alphanumeric code. In the case of CDSL, just enter the CDSL client number. Remember that the NSDL string is alphanumeric while the CDSL string is a numeric string. The details of your DP and client ID are available in your online DP statement or in the statement of account. After that, you can click the Search Button in both cases. Before you see the output, you will be asked to enter a 6-digit numeric Captcha code as given. In case, it is not clear, you can toggle for more options. The captcha is to ensure that the person accessing the allotment status is a human being and not a robot.

·Thirdly, you can also search by Income Tax PAN number. Once you select PAN (permanent account number) from the dropdown menu, enter your 10-digit PAN number, which is an alphanumeric code. Remember, in a PAN, the first to fifth and the tenth characters are alphabets while the sixth to ninth characters are numeric characters. The PAN number will be available on your PAN card or top of your income tax returns filed. Once you enter the PAN, click on the Search Button. Once again, before you see the output, you will be asked to enter a 6-digit numeric Captcha code as given. In case, if it is not clear, you can toggle for more options.

The IPO status with a number of shares of Clinitech Laboratory allotted will be displayed on the screen. You can save a screenshot of the output page for future reference. You can verify the demat credit by the close of 31 July 2024, or later bearing ISIN. In case of any complaints or queries, you can email info@bigshareonline.com or call 022-6263-8200.

IPO allocation and subscriptions: why they matter to IPO allotment status

Here is a break-up of the total shares issued by the company and its quota allocated for different classes of investors. This is the key to your chances of allotment in the IPO.

Data Source: Company RHP

The Clinitech Laboratory IPO offers a total of 602,400 shares, distributed equally between Non-Institutional Investors (NII) and Retail Individual Investors (RII), each receiving 301,200 shares (50% each). Additionally, 31,200 shares (5.18%) are reserved for Market Makers. There are no shares allocated to Anchor Investors. The stock will list on the stock exchanges on the third working day after the closure of the IPO.

Clinitech IPO Subscription Status

The Clinitech Laboratory IPO has been subscribed 38.96 times overall as of July 29, 2024, 5:11:08 PM. The retail category saw the highest subscription at 49.61 times, while the NII category was subscribed 23.28 times. The market maker category was subscribed 1 time. A total of 5,71,200 shares were offered, with bids for 2,22,55,200 shares, totaling Rs 213.65 crores. The IPO received 18,408 applications in total.

Data Source: BSE

Clinitech Laboratory IPO subscribed 38.96 times. The public issue subscribed 49.61 times in the retail category, times in QIB, and 23.28 times in the NII category by July 29, 2024, 5:11:08 PM.

In the above case, the subscription is extremely robust and strong for retail and HNI / NII, and that largely makes the chances of allotment in the IPO substantially lower. This subscription is much higher than the median subscription that BSE-SME IPOs generally get to see. However, it is best to wait for the basis of allotment to be finalized.

About Clinitech Laboratory IPO

Clinitech Laboratory IPO is a fixed price issue of ₹5.78 crores, entirely comprising a fresh issue of 6.02 lakh shares. Open for subscription from July 25, 2024, to July 29, 2024, the allotment is expected to be finalized on Tuesday, July 30, 2024, with the listing on BSE SME tentatively set for Thursday, August 1, 2024. Priced at ₹96 per share, the minimum lot size for application is 1,200 shares, requiring a minimum investment of ₹115,200 for retail investors. High Net-worth Individuals (HNI) need to invest in a minimum of 2 lots (2,400 shares), amounting to ₹230,400. Inventure Merchant Banker Services Pvt Ltd is the book-running lead manager, Bigshare Services Pvt Ltd is the registrar, and Svcm Securities is the market maker for the IPO.

Like every SME IPO, this issue also has a market-making portion. The company has allocated 31,200 shares to the market maker. Svcm Securities will be the market maker to the issue, providing two way-quotes on the stock post listing. The market maker provides two-way quotes to ensure liquidity on the counter and low basis costs. The company has been promoted by Jagdish Umakant Nayak, Jyoti Jagdish Nayak, and Ashutosh Jagdish Nayak. The promoter holding in the company currently stands at 83.63%. However, post the fresh issue of shares, promoter equity holding share will get diluted to 61.56%. The fresh issue funds will be used by the company for the Expansion of Diagnostic Centres.

A small part of the IPO proceeds has also be set aside for general corporate purposes. Inventure Merchant Banker Services Pvt Ltd will be the lead manager to the issue, and Bigshare Services Private Ltd will be the registrar to the issue. The market maker for the issue is yet to be announced officially by the company. The IPO of Clinitech Laboratory will be listed on the SME IPO segment of the BSE.

Next steps in the IPO of Clinitech Laboratory

Investors would do well to remember that the level of subscription is very material as it determines the chances of getting an allotment. Normally, the higher the subscription ratio, the lower the chances of allotment and vice versa. In this case, the subscription levels have been very high in the IPO; both in the Retail segment and also in the HNI / NII segment. Investors in the IPO need to assess their chances of allotment accordingly. The final status will be known once the basis of allotment is finalized and uploaded for you to check. You can apply the above allotment checking process flow after the basis of allotment is finalized.